Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin. - Test2 - elhamkhani - TriplyDB

Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.

Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.

http://www.wikidata.org/entity/Q33587989

about

Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP β/ζ signaling by menin Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer Menin enhances c-Myc-mediated transcription to promote cancer progression Regulation of cyclin B2 expression and cell cycle G2/m transition by menin Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how Tumor suppressor menin represses paired box gene 2 expression via Wilms tumor suppressor protein-polycomb group complex Low dose nicotine attenuates Aβ neurotoxicity through activation early growth response gene 1 pathway.Menin represses tumorigenesis via repressing cell proliferation.EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion.Interplay between menin and K-Ras in regulating lung adenocarcinoma.ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers.Menin mediates epigenetic regulation via histone H3 lysine 9 methylation.Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription Menin represses malignant phenotypes of melanoma through regulating multiple pathways.Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis.Menin: a scaffold protein that controls gene expression and cell signaling.Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase.SUMO modification of menin A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.Epigenetic regulation by the menin pathway.Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.

P2860

Q24339039-B06EE66F-0DD0-4F55-B851-C3708E6E695F Q28296266-76AD8D69-493D-40DE-A765-C5E817E4F5F7 Q28387891-F8DB4562-F960-4044-A6DD-B7C1A7002518 Q33654359-6771D6A9-3B77-44EF-9E24-3412B14214AC Q33897734-54B636BF-A237-4F3B-8466-327A2028526B Q34167625-4DEA67DE-7C2C-4C55-AA4E-E0C2C8862E29 Q34799923-E5FA0294-68C4-4241-AC66-AE2D331006CB Q35223747-3F6C3984-3432-4780-913D-6700D279C986 Q35376284-E06B2A0E-053B-4913-88B8-8B06FA2F79AA Q35758563-1723121C-7DCA-4189-8A48-164C101C6DDB Q36407855-C4D8D3CC-6A1E-4CA9-8CA2-A4AB094FEE76 Q36477122-96D02322-EF5F-4D05-85F4-4675B0C196F4 Q36890205-2E9261A3-4FEC-449E-8454-D49FD0FDBB1F Q37255927-9D729E83-B1B8-467A-8CCF-6C74FE10A749 Q37294848-C5AF5955-F28F-4EA1-82C7-F1F5469AFA52 Q37619445-A8FF2C7E-3796-4498-ACC1-B1F65DDA1892 Q37706202-CF221328-9D1F-4FA8-AFC4-BC72AFAC1EC8 Q38121288-7A6D0994-5364-4243-A9DA-BFDD1E0B0999 Q38290097-51A5DC51-4F2D-48DB-85F9-721FC956C1DF Q41961641-0E73B07E-2AC9-4E77-902B-C37EDB07E188 Q47246743-F87D6C85-093A-4BBC-9F30-1DC959B02F05 Q47948643-D7C65651-E349-40C2-AD44-FAA361826773 Q55712143-3917E6C8-8A4B-4406-A25D-4633072EDCB2

P2860

Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.

http://www.wikidata.org/entity/Q33587989

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@ast

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@en

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@nl

type

label

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@ast

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@en

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@nl

prefLabel

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@ast

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@en

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@nl

P1433

Q33587989-CB9ED18E-1EF8-4F15-BDF4-54A109E871EB

P1476

Q33587989-60F365D0-4A32-482C-ABDE-71E9293A5701

P2093

Q33587989-3447BC64-E086-43BD-AE91-C6533D6CB8D3

Q33587989-376B42C9-5F5D-4DF6-BFD3-DC6DF1F91CBE

Q33587989-66D8E33A-D61D-4A97-B1A5-E729AB3BF143

Q33587989-83D3A31F-6EFD-45F5-B526-2695782CFBCD

Q33587989-BC492009-1388-456F-8295-7CBB353F131C

Q33587989-C6C575EF-513B-4193-928B-CB97E221D308

Q33587989-D596C098-94D8-4C5D-9EE2-331E79CA207A

Q33587989-F362053D-5945-4E95-B5EC-FDDD7325B529

P2860

Q33587989-01C2FA29-5C35-4625-BC7A-462554740777

Q33587989-07B9EEA8-F551-4BFB-ABC0-A5F35CB2AFE5

Q33587989-08AFF03F-AC2F-4BC4-81C8-C1760422BEBC

Q33587989-10ABBBAD-6F0A-4FE2-AD94-9E5EFA79745A

Q33587989-1F593C95-2BC4-4027-88F1-94C9F7A4E258

Q33587989-296E779C-B161-4E84-BB74-F57D4AF0B786

Q33587989-327C4998-1A7E-4984-8BDA-87CCB59BCB22

Q33587989-35A5FA9F-9494-4AB1-AA03-5D9893B228BA

Q33587989-3CAAFECE-8418-4F57-993E-AFD22607E6D6

Q33587989-3D2AEA35-2B59-4CB8-A2CF-424846ACF2A0

P2888

Q33587989-082F8F7E-5469-4DFE-B505-729086A3994B

P304

Q33587989-D436A823-E7E2-480D-855D-942E4388A0DD

P31

Q33587989-513295B3-9238-4178-B3C8-34704D329B12

P356

Q33587989-564AA5A3-F637-49C4-AABF-49AE4174CD95

P407

Q33587989-16501E2B-9D75-4542-B72A-6743F28C59D9

P433

Q33587989-ADB7CDBC-7E2F-4380-BA79-70EC45B93D52

P478

Q33587989-ECC1CB37-E8FB-4CA6-BD24-E75E902111A9

P577

Q33587989-386BFFA3-58DB-45C1-86BB-3876F61B15F0

P5875

Q33587989-6383ED29-91E9-4600-B613-D1984ECF628A

P6179

Q33587989-D31EBD34-F742-41BA-A961-3206B4CB37AC

P698

Q33587989-79CCFA4C-2E67-4140-809B-4BC32C925A6D

P921

Q33587989-1B4E1DC5-FDC0-40F4-AFD8-72262044F417

P932

Q33587989-EBE70A75-31FD-4110-B882-25CC4FAF1F5A

P356

P1433

P1476

Suppression of lung adenocarci ...... of growth factor pleiotrophin.

@en

P2093

B Xu

http://www.w3.org/2001/XMLSchema#string

G-H Jin

http://www.w3.org/2001/XMLSchema#string

P Yin

http://www.w3.org/2001/XMLSchema#string

S-B Gao

http://www.w3.org/2001/XMLSchema#string

X Hua

http://www.w3.org/2001/XMLSchema#string

Y Wu

http://www.w3.org/2001/XMLSchema#string

Y Yang

http://www.w3.org/2001/XMLSchema#string

Z-J Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Cdx4 and menin co-regulate Hoxa9 expression in hematopoietic cells

Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta

Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression

Menin associates with FANCD2, a protein involved in repair of DNA damage

Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors

The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

P2888

P304

4095-4104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2009.273

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26807877

http://www.w3.org/2001/XMLSchema#string

P6179

1003174186

http://www.w3.org/2001/XMLSchema#string

P698

19749796

http://www.w3.org/2001/XMLSchema#string

P921

P932

5399538

http://www.w3.org/2001/XMLSchema#string